Affimers as anti-idiotypic affinity reagents for pharmacokinetic analysis of biotherapeutics
Therapeutic antibodies are the fastest growing class of drugs in the treatment of cancer, and autoimmune and inflammatory diseases that require the concomitant development of assays to monitor therapeutic antibody levels. Here, we demonstrate that the use of Affimer nonantibody binding proteins prov...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Taylor & Francis Group
2019-12-01
|
| سلاسل: | BioTechniques |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.future-science.com/doi/10.2144/btn-2019-0089 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|